These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26629059)

  • 21. Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in Vivo.
    Li HC; Xia ZH; Chen YF; Yang F; Feng W; Cai H; Mei Y; Jiang YM; Xu K; Feng DX
    Cell Physiol Biochem; 2017; 43(5):1829-1840. PubMed ID: 29050003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different mechanisms involved in the berberine-induced antiproliferation effects in triple-negative breast cancer cell lines.
    Lin YS; Chiu YC; Tsai YH; Tsai YF; Wang JY; Tseng LM; Chiu JH
    J Cell Biochem; 2019 Aug; 120(8):13531-13544. PubMed ID: 30957305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-153 promotes breast cancer cell apoptosis by targeting HECTD3.
    Wu X; Li L; Li Y; Liu Z
    Am J Cancer Res; 2016; 6(7):1563-71. PubMed ID: 27508098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of miR-873 contributes to gemcitabine resistance in triple-negative breast cancer via targeting ZEB1.
    Wang G; Dong Y; Liu H; Ji N; Cao J; Liu A; Tang X; Ren Y
    Oncol Lett; 2019 Oct; 18(4):3837-3844. PubMed ID: 31579087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-206 inhibits metastasis of triple-negative breast cancer by targeting transmembrane 4 L6 family member 1.
    Fan C; Liu N; Zheng D; Du J; Wang K
    Cancer Manag Res; 2019; 11():6755-6764. PubMed ID: 31413629
    [No Abstract]   [Full Text] [Related]  

  • 26. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
    Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
    BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
    Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC; Wang JX; Han ML; Zhang LP; Li L
    Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Chen P; He YH; Huang X; Tao SQ; Wang XN; Yan H; Ding KS; Lobie PE; Wu WY; Wu ZS
    Oncotarget; 2017 Oct; 8(46):80709-80721. PubMed ID: 29113338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-490-3p inhibits the growth and invasiveness in triple-negative breast cancer by repressing the expression of TNKS2.
    Jia Z; Liu Y; Gao Q; Han Y; Zhang G; Xu S; Cheng K; Zou W
    Gene; 2016 Nov; 593(1):41-47. PubMed ID: 27506313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction.
    Chen F; Luo N; Hu Y; Li X; Zhang K
    Cell Physiol Biochem; 2018; 47(5):2147-2158. PubMed ID: 29975921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
    Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
    Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147.
    Wang C; Xu C; Niu R; Hu G; Gu Z; Zhuang Z
    BMC Cancer; 2019 Jun; 19(1):577. PubMed ID: 31196010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wnt pathway targeting reduces triple-negative breast cancer aggressiveness through miRNA regulation in vitro and in vivo.
    Mohammadi-Yeganeh S; Hosseini V; Paryan M
    J Cell Physiol; 2019 Aug; 234(10):18317-18328. PubMed ID: 30945294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-182 promotes proliferation and metastasis by targeting FOXF2 in triple-negative breast cancer.
    Zhang X; Ma G; Liu J; Zhang Y
    Oncol Lett; 2017 Oct; 14(4):4805-4811. PubMed ID: 29085483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.
    Elkhalifa D; Siddique AB; Qusa M; Cyprian FS; El Sayed K; Alali F; Al Moustafa AE; Khalil A
    Eur J Med Chem; 2020 Feb; 187():111954. PubMed ID: 31838326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes.
    Li X; Chen W; Jin Y; Xue R; Su J; Mu Z; Li J; Jiang S
    Biochem Pharmacol; 2019 Mar; 161():98-112. PubMed ID: 30639456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
    Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A
    BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    López-Rosas I; López-Camarillo C; Salinas-Vera YM; Hernández-de la Cruz ON; Palma-Flores C; Chávez-Munguía B; Resendis-Antonio O; Guillen N; Pérez-Plasencia C; Álvarez-Sánchez ME; Ramírez-Moreno E; Marchat LA
    Front Cell Infect Microbiol; 2018; 8():437. PubMed ID: 30671387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-454 may function as an oncogene via targeting AKT in triple negative breast cancer.
    Li Q; Liu J; Meng X; Pang R; Li J
    J Biol Res (Thessalon); 2017 Dec; 24():10. PubMed ID: 28795052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.